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Indocyanine green (ICG) , an organic anionic dye removed from the blood exclusively by the liver, has been a useful tool for the study of hepatic physiology and for the evaluation of patients with liver disease. In fact, the rate of disappearance of ICG from plasma following its intravenous administration is one of the more sensitive indicators of hepatic dysfunction (Leevy, Smith, Longueville, Paumgartner, and Howard, 1967) .
Following the demonstration that hepatic uptake of ICG is a saturable process (Hunton, Bollman, and Hoffman, 1961) , Paumgartner, Probst, Kraines, and Leevy (1970) utilized classical MichaelisMenten enzyme kinetics to determine the maximal rate of ICG removal (Rmax) from disappearance rates of multiple, submaximal doses. The discovery of a close correlation between regenerating liver mass in the rat and Rmax by Rikkers and Moody (1974a) encouraged the application of this technique to the clinical estimation of hepatic reserve.
The purposes of the present investigation are twofold: (1) to determine if hepatic removal of ICG in patients with chronic active liver disease follows saturation kinetics, allowing calculation of Rmax, and (2) to assess the role of azathioprine in the management of these patients by evaluating the influence of this drug on Rmax.
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Patients and Methods

PATIENTS
Fourteen patients, eight males and six females, with chronic active liver disease were evaluated. Their ages ranged from 13 to 69 years, and the known duration of liver disease from three months to seven years, exceeding nine months in 11 patients.
In all cases diagnosis was established histologically by percutaneous liver biopsy. All biopsies exhibited piecemeal necrosis, usually with rosette formation, and fibrosis, while 11 displayed disordered architecture consistent with either developing or established cirrhosis. Evidence of portal hypertension or ascites from physical examination, barium studies, or splenoportography could be detected in seven patients. Hepatitis B antigen was present in three cases.
All patients were evaluated with ICG at least once. Three patients were not studied a second time because of haemorrhage from oesophageal varices (one) or unavailability for follow up (two). The remaining 11 patients were divided into two groups: (A) six patients who had not received drug therapy for liver disease over the previous five months, and (B) five patients on maintenance prednisolone, 10 mg per day. The groups were dissimilar with respect to duration of liver disease and incidence of cirrhosis. While all five group B patients had evidence of cirrhosis on biopsy and a history of liver disease for more than a year, only three of six group A patients had these characteristics.
Following (Rikkers and Moody, 1974a; Moody, Rikkers, and Aldrete, 1974) . In summary, the following calculations are necessary:
(1) The initial hepatic removal rate (R) for each of the three ICG doses is derived by multiplying the plasma disappearance rate times dose; (2) azathioprine treatment neither Rmax nor Km were significantly altered in group A or group B. Likewise, no effect on these variables could be detected when groups A and B were combined. Similarly, values after treatment for serum albumin, AST, and total bilirubin were not significantly changed from initial measurements (table II) . Two patients (AC and MM) in group A merit individual consideration. Both Rmax and Km were markedly reduced following azathioprine therapy in both these cases (table I). The Lineweaver-Burk graphs resulting from these studies are presented in figures 1 and 2. The decreased capacity for hepatic ICG removal was accompanied by elevations in total serum bilirubin and AST in MM, while these parameters were not significantly affected in AC. The alterations in ICG Rmax and Km, serum bilirubin, and AST in MM were reversed two weeks following the addition of prednisolone, 15 mg a day, to the azathioprine regimen. AC was not further evaluated. In the only patient (SW) to display a significant improvement in Rmax following azathioprine treatment, the initial measurement was imprecise because of the lack of linearity of the Lineweaver Burk regression.
Comparison of both Rmax and Km with serum albumin, total bilirubin, and AST revealed no significant relationships. However, a significant correlation (p <001) existed between Rmax and the hepatic removal rate (R) for each of the individual ICG doses. The best correlation (r = 0-76) was with the R of the 5*0 mg per kg dose (fig 3) .
Discussion
These results indicate that hepatic removal of incremental doses of ICG is consistent with Michaelis-Menten kinetics in most patients with chronic active liver disease, providing a means of estimating a maximal removal rate (Rmax) for this dye. The mean Rmax of 0 47 ± 0-08 mg per kg per min calculated for this group of patients is considerably less than the values of 3-6 mg per kg per min (Paumgartner et al, 1970 ) and 3 4 mg per kg per min (Moody et al, 1974) previously established for subjects without hepatic dysfunction. All patients in the present series had Rmax values well below these normal values. Patients in group B, all of whom had histologically proven cirrhosis, exhibited an Rmax (0-24 ± 0 04 mg per kg per min) identical to that determined earlier for a population of alcoholic cirrhotics (Moody et al, 1974) . The mean Rmax for group A (0 53 ± 0-08 mg per kg per min), consisting of both cirrhotic (three) and non-cirrhotic (three) patients, was significantly higher.
Two theoretical advantages derive from determination of Rmax. First, since Rmax represents the rate of ICG uptake when the hepatic mechanism for its removal is saturated, this measurement should be a reasonable estimate of the hepatic reserve for this function. Second, because saturation is hypothetically attainable despite alterations in liver blood flow or the presence of competitors for hepatic removal, Rmax should be independent of these factors. Kinetic analysis of hepatic ICG removal in experimental animals has supported both of these postulates. A close correlation between Rmax and liver weight has been demonstrated in rats following partial hepatectomy and at various intervals during regeneration, indicating that this parameter, at least in these circumstances, is an accurate reflection of functional hepatic mass or reserve (Rikkers and Moody, 1974a) . The organic anions bilirubin and rifamycin, known to compete with ICG for hepatic uptake, do not alter Rmax when simultaneously administered with ICG to normal rats (Paumgartner et al, 1970) . In addition, patients with hyperbilirubinaemia secondary to extrahepatic biliary obstruction, but with well preserved hepatocellular function, often have near normal Rmax values (Moody et al, 1974) .
Because of the complexity of physiological, biochemical, and metabolic derangements accompanying chronic liver disease, such clear and predictable relationships might not be expected either between Rmax and liver mass or between Rmax and other laboratory indices of liver function in patients with these disorders. And, in fact, in the present study no correlation existed between either Rmax or Km and serum albumin, total bilirubin, or AST. A similar finding for a variety of hepatic diseases has previously been reported (Moody et al, 1974) . The fact that the two patients (MM and MN) with the lowest Rmax values had normal serum albumin levels implies that, even though Rmax for ICG may truly reflect the liver's reserve for organic anion uptake, this measurement is not necessarily a reliable indicator of the competence of other hepatic processes. Because of the multiplicity of functions performed by the liver, this same limitation pertains to other quantitative methods such as the galactose elimination capacity (Tygstrup, 1966) , and the excretory Tm for sulphobromopthalein (BSP) (Wheeler, Meltzer, and Bradley, 1960) .
Significant disadvantages of this technique are its relatively high cost and the three-day period required for determining Rmax. The cost of the dye alone needed for a three-dose test in a person of 70 kg is approximately $75. Because precise measurement of Rmax requires stable hepatic function and blood flow over the test interval, the method is not applicable to acute liver disease or other situations accompanied by rapid alterations in these factors. Therefore, an important finding in the present study is the strong correlation between Rmax and the removal rate (R) of a 5*0 mg per kg ICG dose, making the estimation of hepatic removal capacity for this anion from a single large dose possible in most cases. A similar close relationship between Rmax and 5*0 mg per kg R has been found in a wide spectrum of liver and biliary tract disease by Moody and his coworkers (Moody et al, 1974) . In addition, a reliable estimation of regenerating liver mass in the dog from hepatic removal rate of a 10 mg per kg ICG dose lends further support to the feasibility of a single-dose approximation of hepatic reserve (Rikkers and Moody, 1974b) .
Corticosteroids prolong survival and improve standard biochemical tests of liver function in patients with chronic active liver disease (Cook, Mulligan, and Sherlock, 1968; Soloway, Summerskill, Baggenstoss, Geall, Gitnick, Elveback, and Schoenfeld, 1972) . These drugs also have a beneficial influence on hepatic organic anion uptake as evidenced by significantly decreased BSP retention, relative hepatic storage (S) for BSP (Cook, Velasco, and Sherlock, 1968) , and, in the present study, an impressive increase in ICG Rmax in the only patient (MM) studied before and after treatment with prednisolone.
Unfortunately, the relatively high frequency of undesirable side effects associated with corticosteroids limits their usefulness in many patients. Therefore azathioprine, a drug which is free of the complications accompanying steroid therapy, has been utilized in the treatment of chronic active liver disease. However, in a prospective controlled trial, although the combination of azathioprine and low-dose prednisone improved prognosis, patients treated with azathioprine alone fared no better than those given placebos (Soloway et al, 1972) .
Because of its questionable efficacy, we have examined the influence of azathioprine on hepatic reserve as measured by ICG Rmax in patients with chronic active liver disease. Following two weeks of treatment with azathioprine we could detect no improvement in Rmax in previously untreated patients (group A), those on maintenance prednisolone (group B), or both groups combined. Thus, it appears that, at least over the short term, azathioprine has no beneficial influence on the liver's reserve for ICG removal in these patients.
The use of azathioprine in various non-hepatic diseases has occasionally resulted in liver toxicity, manifested by portal fibrosis and cholestasis (Du Vivier, Munro, and Verbov, 1974; Zarday, Veith, Gliedman, and Soberman, 1972) . Although difficult to distinguish from the natural course of the disease, this drug is also thought to have a detrimental effect on hepatic function in some patients with chronic active liver disease (Soloway et al, 1972) . Two previously untreated patients (AC and MM) from the present study experienced marked reductions in Rmax following therapy with azathioprine. The depression in Rmax after treatment was accompanied by a worsening of standard liver function indices in one (MM), but not the other (AC). AC was a Negro female aged 13 and MM a 30-year-old male Arab. Both had a relatively brief history of liver disease (<five months) and very active hepatitis biochemically and histologically. AC also exhibited early histological evidence of cirrhosis. Hepatitis B antigen was the aetiological agent in MM while AC displayed immunological aberrations consistent with 'lupoid hepatitis' (elevated titres of smooth muscle, antinuclear, and anti-DNA antibodies, and a total globulin level of 6-0 g %). Before treatment Rmax was relatively high (073 and 071 mg per kg per min) in both cases.
Although the mechanism of azathioprine's proposed hepatoxicity has not been elucidated, it is known that the immunosuppressive activity of this drug, as measured by the rosette inhibition test, is dependent upon adequate hepatic function (Wheland and Sherlock, 1972) . If the toxic potential of azathioprine also requires activation by the liver, it is not surprising that an adverse effect of the drug was detected in the two patients with the highest values for ICG Rmax. Another possibility is that the deterioration in Rmax in these two patients simply represents progression of their disease. However, the magnitude of the decrease coupled with the short period between analyses makes this unlikely.
Finally, it should be emphasized that patients were evaluated only over a relatively brief treatment 4 interval. What effect long-term azathioprine therapy might have on hepatic ICG extraction is not known. 
